Legal Disclaimer
GLP-1 receptor agonist therapies (including Tirzepatide, Retatrutide, and Semaglutide) offered at Pedersen Medicine are compounded medications prescribed by a licensed physician following a comprehensive clinical evaluation. Compounded GLP-1 medications are not FDA-approved finished drug products and are not equivalent to brand-name medications such as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. Compounded medications are not subject to FDA pre-market approval.
Pricing listed reflects monthly medication cost only. Consultation fees, laboratory work, and ongoing clinical oversight fees are separate and may apply. All pricing is subject to change without notice. A physician consultation and appropriate lab work are required prior to initiating any GLP-1 protocol.
Results vary based on individual physiology, adherence to protocol, dietary habits, physical activity, and overall health status. No specific outcomes are guaranteed. This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before beginning any weight management program.